As cancer care becomes increasingly driven by complex, high-cost therapies, health systems are rethinking how tightly ...

This new global meeting will bring together a carefully curated group of international leaders across oncology, haematology, ...

Explore the complexities of modern oncology, including precision medicine, CAR T-cell therapies, and challenges in breast ...

Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces ...

Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to share their top 2026 priority for ...

LOUISVILLE, Ky., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Onco360 ®, the nation’s leading independent specialty pharmacy, has been chosen by Rigel Pharmaceuticals as limited distribution specialty pharmacy ...

Onco360(R) , the nation's leading independent Specialty Pharmacy, has been selected as the national pharmacy partner by Sun Pharmaceuticals for UNLOXCYT(TM) (cosibelimab-ipdl). UNLOXCYT is the first ...

LOUISVILLE, K.Y., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Onco360 ®, the nation’s leading independent Specialty Pharmacy, has been selected as the national pharmacy partner by Sun Pharmaceuticals for ...

The relief measure includes targeted therapies such as Ribociclib, used in certain breast cancer treatments and Darolutamide, prescribed for prostate cancer.

Cencora is transitioning from a traditional wholesale logistics model to a higher margin specialty services model. Click here to find out why COR is a Buy.